Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society

被引:0
作者
Rodacki, Melanie [1 ]
Zajdenverg, Lenita [1 ]
da Silva Jr, Wellington Santana [2 ]
Giacaglia, Luciano [3 ]
Negrato, Carlos Antonio [4 ]
Cobas, Roberta Arnoldi [5 ]
de Almeida-Pititto, Bianca [6 ]
Bertoluci, Marcello Casaccia [7 ]
机构
[1] Univ Fed Rio De Janeiro, Dept Clin Med Nutrol, Rio De Janeiro, Brazil
[2] Univ Fed Maranhao, Dept Med 1, Disciplina Endocrinol, Sao Luis, Brazil
[3] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil
[4] Univ Sao Paulo, Fac Med Bauru, Bauru, Brazil
[5] Univ Estado Rio De Janeiro, Fac Ciencias Med, Dept Med Interna, Rio De Janeiro, Brazil
[6] Univ Fed Sao Paulo, Dept Med Prevent, Escola Paulista Med, Sao Paulo, Brazil
[7] Univ Fed Rio Grande do Sul, Serv Endocrinol Hosp Clin Porto Alegre, Fac Med, Porto Alegre, Brazil
关键词
Practice guidelines: type 2 diabetes mellitus; Prediabetic state; Blood glucose; Glycated hemoglobin; Oral glucose tolerance test; Diagnosis; Early diagnosis; Disease prevention; FASTING PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; METABOLIC SYNDROME; OBESE CHILDREN; TOLERANCE TEST; LIFE-STYLE; FOLLOW-UP; OGTT; PREVALENCE;
D O I
10.1186/s13098-024-01572-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with type 2 diabetes (T2D) often experience prolonged periods of asymptomatic hyperglycemia, which significantly increases the risk of developing chronic complications related to diabetes. Screening programs for individuals at high risk for T2D provide valuable opportunities not only for early diagnosis but also for detecting intermediate hyperglycemic states, commonly referred to as prediabetes. Interventions aimed at preventing diabetes in this group can successfully delay or even avoid the onset of the disease and its associated burdens. This review is an update of the Brazilian Diabetes Society (Sociedade Brasileira de Diabetes [SBD]) evidence-based guideline for diagnosing diabetes and screening T2D. Methods The methodology was previously published and defined by the internal institutional steering committee. The working group drafted the manuscript by selecting vital clinical questions for a narrative review, utilizing MEDLINE via PubMed to identify relevant studies. The review assessed the best available evidence, including randomized clinical trials (RCTs), meta-analyses, and high-quality observational studies related to the diagnosis of diabetes. Results and conclusions Fifteen specific recommendations were formulated. Screening is recommended for adults aged 35 and older or younger individuals with obesity and additional risk factors. For children and adolescents, screening is recommended starting at age ten or the onset of puberty if they are overweight or obese and have additional risk factors. Fasting plasma glucose (FPG) and HbA1c are recommended as initial screening tests. The oral glucose tolerance test (OGTT) is recommended for high-risk individuals with normal HbA1c and FPG or those with prediabetes. The 1-h OGTT is preferred over the 2-h OGTT, as it is both more practical and a superior test. A structured approach to reevaluation intervals is provided.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Screening for Type 1 and Type 2 Diabetes
    Ekoe, Jean-Marie
    Punthakee, Zubin
    Ransom, Thomas
    Prebtani, Ally P. H.
    Goldenberg, Ronald
    CANADIAN JOURNAL OF DIABETES, 2013, 37 : S12 - S15
  • [42] Screening for type 2 diabetes mellitus
    Peer, Nasheeta
    Balakrishna, Yusentha
    Durao, Solange
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (05):
  • [43] Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement
    Kalyani, Rita R.
    Allende-Vigo, Myriam Z.
    Antinori-Lent, Kellie J.
    Close, Kelly L.
    Das, Sandeep R.
    Deroze, Phyllisa
    Edelman, Steven, V
    El Sayed, Nuha A.
    Kerr, David
    Neumiller, Joshua J.
    Norton, Anna
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (05) : 1155 - 1178
  • [44] Screening for Type 2 Diabetes and Dysglycemia
    Echouffo-Tcheugui, Justin B.
    Ali, Mohammed K.
    Griffin, Simon J.
    Narayan, K. M. Venkat
    EPIDEMIOLOGIC REVIEWS, 2011, 33 (01) : 63 - 87
  • [45] Automatic laboratory-based strategy to improve the diagnosis of type 2 diabetes in primary care
    Salinas, Maria
    Lopez-Garrigos, Maite
    Flores, Emilio
    Leiva-Salinas, Maria
    Lugo, Javier
    Pomares, Francisco J.
    Asencio, Alberto
    Ahumada, Miguel
    Leiva-Salinas, Carlos
    BIOCHEMIA MEDICA, 2016, 26 (01) : 121 - 128
  • [46] Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement
    Davidson, Karina W.
    Barry, Michael J.
    Mangione, Carol M.
    Cabana, Michael
    Caughey, Aaron B.
    Davis, Esa M.
    Donahue, Katrina E.
    Doubeni, Chyke A.
    Krist, Alex H.
    Kubik, Martha
    Li, Li
    Ogedegbe, Gbenga
    Owens, Douglas K.
    Pbert, Lori
    Silverstein, Michael
    Stevermer, James
    Tseng, Chien-Wen
    Wong, John B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (08): : 736 - 743
  • [47] Pharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM)
    Al-Sofiani, Mohammed E.
    Batais, Mohammed A.
    Aldha, Essa
    Alzaid, Aus
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (03) : 891 - 899
  • [48] Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease
    Gignac, Theo
    Trepanier, Gabrielle
    Paquet, Veronique
    Ferland, Stephanie
    Carreau, Anne-Marie
    CANADIAN JOURNAL OF DIABETES, 2023, 47 (07) : 603 - 610
  • [49] Use of HbA1c in Screening for Cuban-Americans with Undiagnosed Type 2 Diabetes
    Huffman, Fatma G.
    Exebio, Joel C.
    Zarini, Gustavo G.
    Exebio, Cristobal
    JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 2011, 13 (03) : 541 - 545
  • [50] Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Bae, Jaehyun
    Han, Eugene
    Lee, Hye Won
    Park, Cheol-Young
    Chung, Choon Hee
    Lee, Dae Ho
    Cho, Eun-Hee
    Rhee, Eun-Jung
    Yu, Ji Hee
    Park, Ji Hyun
    Bae, Ji-Cheol
    Park, Jung Hwan
    Choi, Kyung Mook
    Kim, Kyung-Soo
    Seo, Mi Hae
    Lee, Minyoung
    Kim, Nan-Hee
    Kim, So Hun
    Lee, Won-Young
    Lee, Woo Je
    Choi, Yeon-Kyung
    Lee, Yong-ho
    Hwang, You-Cheol
    Lyu, Young Sang
    Lee, Byung-Wan
    Cha, Bong-Soo
    DIABETES & METABOLISM JOURNAL, 2024, 48 (06) : 1015 - 1028